Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. (Q36956727)
Jump to navigation
Jump to search
scientific article published on 30 July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. |
scientific article published on 30 July 2008 |
Statements
Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy (English)
Matthias Kretzler
Frank C Brosius
Jaeman Byun
Subramaniam Pennathur
Hongyu Zhang
Jharna Saha
MaryLee Schin
Matthew Lorenz
30 July 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference